3 unchanged sentences
(c) Director and Officer Trading Plans and Arrangements
+Added: On August 30, 2024 , Frank McCormick , a member of our Board of Directors , adopted a trading plan on behalf of the Francis P.
+Added: McCormick Revocable Trust U/A DTD 1/27/2017, of which Dr.
+Added: McCormick is a trustee, for the sale of a maximum of 300,000 shares of our common stock (the “Trading Plan”).
+Added: The Trading Plan is intended to satisfy the affirmative defense conditions of the Securities and Exchange Act Rule 10b5-1(c) and is expected to remain in effect until the earlier of (1) November 26, 2025 and (2) the date on which an aggregate of 300,000 shares of our common stock have been sold under such plan.
Exhibit Title
25 unchanged sentences
September 25, 2023
−Removed: Second Amendment to Financing Agreement, dated as of June 20, 2024, by and among the Registrant, the Guarantors party thereto, the Lenders party thereto, and Blue Owl Capital Corporation as Administrative Agent.
−Removed: Filed herewith
−Removed: 2021 Amended and Restated BridgeBio Pharma, Inc.
−Removed: Stock Option and Incentive Plan and forms of award agreements thereunder.
−Removed: Filed herewith
+Added: Transaction Agreement, dated as of August 16, 2024, by and among BridgeBio Pharma, Inc., Viking Global Opportunities Illiquid Investments Sub-Master LP, Viking Global Opportunities Drawdown (Aggregator) LP, Patient Square Bravo Aggregator, LP, SC US/E GROWTH FUND X MANAGEMENT, L.P., SC US/E Venture Fund XVIII Management, L.P., Frazier Life Sciences XI, L.P., Frazier Life Sciences Public Fund, L.P., Frazier Life Sciences Public Overage Fund, L.P., Cormorant Private Healthcare Fund IV, LP, Cormorant Private Healthcare Fund V, LP, Cormorant Global Healthcare Master Fund, LP, Aisling V Bridge Splitter LP, Kumar Haldea Revocable Trust and GondolaBio, LLC.
+Added: August 21, 2024
+Added: Amended and Restated Limited Liability Company Agreement of GondolaBio, LLC, dated as of August 16, 2024.
+Added: August 21, 2024
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 .
24 unchanged sentences
Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.
+Added: ** Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5).
# Indicates a management contract or any compensatory plan, contract or arrangement.
2 unchanged sentences
BridgeBio Pharma, Inc.
−Removed: August 1, 2024
+Added: November 12, 2024
/s/ Neil Kumar
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 1, 2024
+Added: November 12, 2024
/s/ Brian Stephenson
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.